Hypothalamic Obesity Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight
(Albany, US) DelveInsight has launched a new report on “Hypothalamic Obesity – Market Insights, Epidemiology, and Market Forecast-2030“
DelveInsight’s “Hypothalamic
Obesity Market Insights, Epidemiology, and Market Forecast-2030“ report
delivers an in-depth understanding of the Hypothalamic Obesity, historical and
forecasted epidemiology as well as the Hypothalamic Obesity market trends in
the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and
Japan.
- According
to DelveInsight, the total prevalent population of Hypothalamic Obesity
(HO) in the 7MM reported to be 20,663 in 2017.
- Among
the 7MM, the US had the highest prevalent cases of Hypothalamic Obesity
with 11,663 cases in 2017. Among the EU5 countries, Germany had the
highest prevalent population of Hypothalamic Obesity with 1656 cases,
followed by UK and the France.
- Spain
had the lowest Hypothalamic Obesity prevalent population of 972 in 2017.
- As
per our estimates, Japan had 2127 prevalent cases of Hypothalamic Obesity
in 2017.
Request for free sample report: https://www.delveinsight.com/sample-request/hypothalamic-obesity-market
View Report: https://www.delveinsight.com/report-store/hypothalamic-obesity-market
- The
report covers the descriptive overview of Hypothalamic Obesity, explaining
its causes, signs and symptoms, pathophysiology, diagnosis and currently
available therapies
- Comprehensive
insight has been provided into the Hypothalamic Obesity epidemiology and
treatment in the 7MM
- Additionally,
an all-inclusive account of both the current and emerging therapies for
Hypothalamic Obesity are provided, along with the assessment of new
therapies, which will have an impact on the current treatment landscape
- A
detailed review of Hypothalamic Obesity market; historical and forecasted
is included in the report, covering drug outreach in the 7MM
- The
report provides an edge while developing business strategies, by
understanding trends shaping and driving the global Hypothalamic Obesity
market
Request for free sample report: https://www.delveinsight.com/sample-request/hypothalamic-obesity-market
View Report: https://www.delveinsight.com/report-store/hypothalamic-obesity-market
Hypothalamic
obesity refers to obesity that is caused by physical or inborn
damage to the hypothalamus. The hypothalamus is part of the brain that
makes hormones that control specific body functions such as sleep,
body temperature, and hunger. It also makes hormones that control
other organs in the body, especially the pituitary gland.
The symptoms of hypothalamic obesity vary by the cause and
include
- Uncontrollable
hunger
- Rapid,
excessive weight gain
- Low
metabolic rate.
If the pituitary gland is involved, symptoms may include small
underdeveloped testes in males and delayed puberty. This condition
most often occurs because of injury to the hypothalamus due to a tumor,
swelling in the brain, brain surgery, or head trauma. The diagnosis is made by
physical examination and review of the symptoms. There is no cure for
hypothalamic obesity. Treatment involves a combination of surgery,
medications, and nutritional and lifestyle counselling.
Some of the Hypothalamic
Obesity Companies Covered:
- Saniona
- Amylin
Pharmaceuticals
- AstraZeneca
- And
Many Others
Hypothalamic
Obesity Drugs Covered:
- Tesomet
- Exenatide
- And
Many Others
View Report: https://www.delveinsight.com/report-store/hypothalamic-obesity-market
Request for free sample report: https://www.delveinsight.com/sample-request/hypothalamic-obesity-market
Table of Contents:
- Key Insights
- Executive Summary of Hypothalamic
Obesity
- Competitive Intelligence Analysis for
Hypothalamic Obesity
- Hypothalamic Obesity: Market Overview at
a Glance
- Hypothalamic Obesity: Disease Background
and Overview
- Patient Journey
- Hypothalamic Obesity Epidemiology and
Patient Population
- Treatment Algorithm, Current Treatment,
and Medical Practices
- Unmet Needs
- Key Endpoints of Hypothalamic Obesity
Treatment
- Marketed Products
- Emerging Therapies
- Hypothalamic Obesity: Seven Major Market
Analysis
- Attribute analysis
- 7MM: Market Outlook
- Access and Reimbursement Overview of
Hypothalamic Obesity
- KOL Views
- Market Drivers
- Market Barriers
- Appendix
- DelveInsight Capabilities
- Disclaimer
Request for detailed TOC: https://www.delveinsight.com/sample-request/hypothalamic-obesity-market
About DelveInsight
DelveInsight is a leading Life Science market research and
business consulting company recognised for its off-the-shelf syndicated market
research reports as well as customised solutions to firms in the healthcare
sector.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Comments
Post a Comment